Cellomatics has been shortlisted as a finalist in the Best CRO category of the 13th Annual OBN Awards.
The winners will be announced in person at the 2021 OBN Awards ceremony on Thursday 25 November at the Ashmolean Museum in Oxford.
The OBN Awards, now in their 13th year, are highly regarded UK awards for the Life Sciences industry and aim to celebrate individuals and companies that have made an outstanding impact in their field. The Awards shine a light on companies at all stages of development, recognising inspirational leadership, exciting innovation, novel and exciting approaches to unmet clinical need, outstanding company progression and the delivery of real-life tangible results.
The twelve categories awarded on the night encompass the biotech, medtech and digital health sectors, as well as recognising dealmakers and those who provide critical support to innovators across the industry.
Commenting on the announcement, CEO and Founder, Shailendra Singh, said: “We have experienced year-on-year growth, which has been driven by an increase in demand for preclinical expertise. This demand for CRO services like ours continues to grow and it is an honour to be recognised as a finalist in the Best CRO category at this year’s awards.”
For more information on the OBN Awards, click here.
